Skip to main content
Department of Pathology

Research

The main interest of research in our department is the application of recent pathological research methodologies to understand the pathogenesis, improve the diagnosis and predict the prognosis of human disease.

The department collaborates with other clinical departments in different research fields and theses. It also provides research opportunities for postgraduates and staff from the department and from any other discipline both from Egypt and abroad.

The main research facilities available at the department:

  1. Histopathological examination and evaluation of tissues .
  2. Cytopathological assessment of exfoliative and FNA cytology.
  3. immunohistochemical – based researches.

         Research Plan

# Title Research Year
101 RASAGILINE PROTECTIVE EFFECT ON ROTENONE-INDUCED NEUROTOXICITY IN MICE 2015
102 Expression of Ezrin and Intercellular Adhesion Molecule-1 (ICAM-1) in Hepatocellular Carcinoma and Non-Neoplastic Liver Lesions of HCV Positive Patients. 2015
103 Cytoskeletal focal adhesion proteins fascin-1 and paxillin are predictors of malignant progression and poor prognosis in human breast cancer‏ 2015
104 Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study. 2015
105 The effects of alpha-lipoic acid on breast of female albino rats exposed to malathion: Histopathological and immunohistochemical study. 2015
106 Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study. 2015
107 Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: A comparative immunohistochemical study 2015
108 Assessment of nestin and hypoxia inducible factor-1 alpha in apparently normal brain tissue/peritumoral areas adjacent to astrocytomas 2014
109 TP73, An Under-Appreciated Player in Non-Hodgkin Lymphoma Pathogenesis and Management 2014
110 Serum profiles of extracellular matrix degradation inhibitors across the stages of liver fibrosis in chronic hepatitis C patients. Assiut Med.J 2014